|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,405 IDR | -1.75% |
|
+0.36% | -12.73% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
PT Kalbe Farma Tbk. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 21,181,770.63 million compared to IDR 19,098,695.08 million a year ago.
Net income was IDR 2,485,513.99 million compared to IDR 2,287,734.41 million a year ago. Basic earnings per share from continuing operations was IDR 53.43 compared to IDR 48.81 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.73% | 4.01B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PT KALBE FARMA TBK. 
